Published • loading... • Updated
West Pharmaceutical: Q3 Earnings Snapshot
The medical device maker said higher volumes and a favorable mix lifted quarterly results and prompted a higher full-year sales and profit forecast.
Summary by LancasterOnline
4 Articles
4 Articles
West Pharmaceutical Services (NYSE:WST) Issues Earnings Results
West Pharmaceutical Services (NYSE:WST - Get Free Report) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $2.66 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $0.46. The company had revenue of $874.50 million for the quarter, compared to analysts' expectations of $827.12 million. West Pharmaceutical Services had a net margin of 16.98% and a return on equity of 20.…
·Sioux Falls, United States
Read Full Article
Coverage Details
Total News Sources4
Leaning Left1Leaning Right1Center2Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 25%
C 50%
R 25%
Factuality
To view factuality data please Upgrade to Premium
